How to Use Vyzulta

How do I take VYZULTA?

  • VYZULTA should be used once daily at night
  • Do not administer VYZULTA more than once daily
  • It is important that you remember to take your drops each night around the same time to help ensure your medication is working effectively

Steps for taking VYZULTA:

Step 1:

Wash your hands.

Step 2:

Tilt your head back. Gently pull your lower eyelid down to form a pocket for the drop.

Step 3:

Administer 1 drop of VYZULTA into the pocket of the eye(s) being treated.

Step 4:

Keep your eyes closed and gently press on the inner part of the eye for 30 seconds to keep VYZULTA in contact with the eye for longer.

Keep your VYZULTA eye drops
from becoming contaminated:

Avoid touching the tip of the container to the eye or any other surface, including a finger, in order to avoid contamination of the solution by bacteria. Serious damage to the eye and possible loss of vision may result from using contaminated solutions.

VYZULTA FAQs

  • Can I use VYZULTA if I wear contact lenses?

    If you wear contact lenses, remove them prior to administering VYZULTA. After administering VYZULTA, wait 15 minutes before reinserting your contact lenses.

  • What if I use other eye drops?

    If you are using other eye drops in addition to VYZULTA, wait 5 minutes between using each type of eye drop.

  • How do I store VYZULTA?

    Store unopened bottles in a refrigerator. Once a bottle is opened, it may be stored at room temperature for up to
    8 weeks. Do not freeze bottles of VYZULTA.

After your doctor has prescribed you VYZULTA, you will need to
place it in the fridge until you are ready to use it for the first time.

Sign up to receive updates and learn more about VYZULTA

Sign up to receive updates and learn more about VYZULTA

By submitting your information you confirm you have read and agree with the terms of our Privacy Policy and Legal Notice.

By submitting your information you confirm you have read and agree with the terms of our Privacy Policy and Legal Notice.

INDICATION

VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension.

IMPORTANT SAFETY INFORMATION 
  • Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued.
  • Gradual changes to eyelashes may occur, including increased length, thickness, color, number of eyelashes and/or direction of eyelash growth. These changes may result in a difference in appearance of each eye. These changes are usually reversible after VYZULTA treatment is discontinued.
  • Avoid touching the tip of the container to the eye or any other surface, including a finger, in order to avoid contamination of the solution by bacteria. Serious damage to the eye and possible loss of vision may result from using contaminated solutions.
  • Tell your doctor immediately about any change in your eye, any eye condition that develops, any sudden change in your vision, any eye side effects, or if you have eye surgery.
  • Remove contact lenses before putting VYZULTA in your eyes. Lenses may be reinserted 15 minutes later.
  • If you are using other eye drops in addition to VYZULTA, wait 5 minutes between using each type of eye drop.
  • The most common side effects seen in studies were eye redness, eye irritation, eye pain, and pain after putting the drops in your eye.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information >

SEE MORE

INDICATION

VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension.

IMPORTANT SAFETY INFORMATION 
  • Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued.